Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 507 of 1,261

  1. US 10253102

    Antigen-binding proteins that activate the leptin receptor

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  2. US 10253024

    Polycyclic indoline and indolenine compounds

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  3. US 10253044

    9H-pyrimido [4,5-b]indoles and related analogs as BET bromodomain inhibitors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  4. US 10252997

    Monocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  5. US 10251955

    Heparin-mimicking sulfonated reverse thermal gel for the delivery of heparin-binding therapeutic proteins

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  6. US 10252039

    Therapeutic agent preparations into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  7. US 10252974

    Cationic lipid

    Takeda Pharmaceutical Company Limited · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  8. US 10251959

    Oligomer-beta blocker conjugates

    Nektar Therapeutics · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  9. US 10251914

    Compositions and methods for transplantation of colon microbiota

    Regents of the University of Minnesota · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  10. US 10251912

    MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  11. US 10251909

    Potassium-magnesium citrate as a surrogate of the DASH diet in managing hypertension

    The Board of Regents of the University of Texas System · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  12. DE 102017122807

    Orales Schilddrüsentherapeutikum

    BERLIN CHEMIE AG [DE] · Granted Apr 4, 2019 · Expires Mar 30, 2039

    granted

  13. US 10249389

    Individual and cohort pharmacological phenotype prediction platform

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 2, 2019 · Expires Mar 28, 2039

    granted

  14. US 10246463

    Hypoxia-inducible factor 1 (HIF-1) inhibitors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 2, 2019 · Expires Mar 28, 2039

    granted

  15. US 10245322

    Nanostructured carriers for guided and targeted on-demand substance delivery

    The Regents of the University of California · Granted Apr 2, 2019 · Expires Mar 28, 2039

    granted

  16. US 10246508

    Anti eotaxin-2 antibodies that recognize additional CCR3-binding chemokines

    CHEMOMAB LTD. · Granted Apr 2, 2019 · Expires Mar 28, 2039

    granted

  17. US 10246464

    Thienopyrimidine and thienopyridine compounds and methods of use thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 2, 2019 · Expires Mar 28, 2039

    granted

  18. US 10245255

    Compositions and methods for the treatment of obesity and related disorders

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 2, 2019 · Expires Mar 28, 2039

    granted

  19. US 10245259

    Methods of treating RBP4 related diseases with triazolopyridines

    Belite Bio, Inc · Granted Apr 2, 2019 · Expires Mar 28, 2039

    granted

  20. US 10245330

    Compositions and methods for imaging

    The Regents of the University of California · Granted Apr 2, 2019 · Expires Mar 28, 2039

    granted

  21. US 10246483

    Bile acid analogs as FXR/TGR5 agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Apr 2, 2019 · Expires Mar 28, 2039

    granted

  22. US 10246416

    Process for preparing [(3-hydroxypyridine-2-carbonyl)amino] alkanoic acids, esters and amides

    Akebia Therapeutics, Inc. · Granted Apr 2, 2019 · Expires Mar 28, 2039

    granted

  23. US 10246713

    TMPRSS6 iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Apr 2, 2019 · Expires Mar 28, 2039

    granted

  24. US 10246707

    Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means

    BIOMARIN TECHNOLOGIES B.V. · Granted Apr 2, 2019 · Expires Mar 28, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.